Medicine
INFeD 100 mg/2 mL injection
INFeD 100 mg/2 mL injection is a prescription medicine containing Iron dextran for intramuscular, intravenous use, marketed by Allergan, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at 20°C to 25°C (68°F to 77°F), excursions permitted to 15°C to 30°C…
Key facts
- Active ingredient (INN)
- Iron dextran
- Brand
- INFeD
- Strength
- 100 mg/2 mL
- Dosage form
- Injection
- Route
- Intramuscular, intravenous
- Packs
- 10 vials of 2 mL, 1 vial of 2 mL
- Marketing authorisation holder
- Allergan
- Manufacturers
- AllerganHenry Schein
- Origin register
- US FDA, United States
- Storage
- Store at 20°C to 25°C (68°F to 77°F), excursions permitted to 15°C to 30°C (59°F to 86°F).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 29 April 1974
- Identifiers
- RxCUI 206216, 311144DailyMed set ID 99bf34be-cb8a-46d1-9637-5544dc2da287, 94b01b1e-794b-4bea-8e24-2e54683fc023NDC 0404-9879, 0023-6082Application NDA017441
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 10 vial, single-dose in 1 carton / 2 mL in 1 vial, single-dose | 0023-6082-10 | Allergan | 29 April 1974 |
| 1 vial, single-dose in 1 bag / 2 mL in 1 vial, single-dose | 0404-9879-02 | Henry Schein | 11 January 2022 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 25 April 1957 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Alternatives
Other makers and brands of Iron dextran 100 mg/2 mL injection.
Clinical summary
Iron dextran is a parenteral iron replacement indicated for treatment of adult and pediatric patients of age 4 months and older with documented iron deficiency, among other approved uses. MedsAcross supplies Iron dextran for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about Iron dextranFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- INFeD prescribing information (Allergan) · U.S. National Library of Medicine, DailyMed
Need INFeD 100 mg/2 mL injection for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.